A E Maluish

1.1k total citations
16 papers, 875 citations indexed

About

A E Maluish is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, A E Maluish has authored 16 papers receiving a total of 875 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 8 papers in Oncology and 2 papers in Molecular Biology. Recurrent topics in A E Maluish's work include Immune Cell Function and Interaction (8 papers), Immunotherapy and Immune Responses (4 papers) and Immune Response and Inflammation (3 papers). A E Maluish is often cited by papers focused on Immune Cell Function and Interaction (8 papers), Immunotherapy and Immune Responses (4 papers) and Immune Response and Inflammation (3 papers). A E Maluish collaborates with scholars based in United States, Australia and Italy. A E Maluish's co-authors include R B Herberman, D M Strong, Tetsuhisa Goto, Stephen A. Sherwin, R. K. Oldham, W.J. Halliday, William H. Isbister, Ronald G. Steis, Dan L. Longo and J Ochs and has published in prestigious journals such as JAMA, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

A E Maluish

16 papers receiving 805 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
A E Maluish United States	14	570	248	160	94	76	16	875
Ugur Üçer Germany	10	589 1.0×	176 0.7×	227 1.4×	120 1.3×	28 0.4×	17	869
Sinikka Hirvonen Finland	12	357 0.6×	193 0.8×	171 1.1×	109 1.2×	40 0.5×	15	702
Félix A. Montero‐Julian France	17	538 0.9×	296 1.2×	227 1.4×	105 1.1×	50 0.7×	27	940
Richard D. Maca United States	15	273 0.5×	131 0.5×	207 1.3×	71 0.8×	92 1.2×	33	722
M Papiernik France	18	861 1.5×	172 0.7×	179 1.1×	72 0.8×	30 0.4×	48	1.2k
Connie Clark United States	8	442 0.8×	116 0.5×	151 0.9×	131 1.4×	99 1.3×	18	767
Dieter Fritze Germany	13	199 0.3×	228 0.9×	154 1.0×	52 0.6×	63 0.8×	56	802
Chantal Moratz United States	16	617 1.1×	247 1.0×	358 2.2×	74 0.8×	110 1.4×	28	1.1k
Richard S. Schulof United States	15	249 0.4×	140 0.6×	152 0.9×	109 1.2×	52 0.7×	30	657
Hsiu-san Lin United States	16	293 0.5×	192 0.8×	162 1.0×	66 0.7×	121 1.6×	29	827

Countries citing papers authored by A E Maluish

Since Specialization

Citations

This map shows the geographic impact of A E Maluish's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A E Maluish with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A E Maluish more than expected).

Fields of papers citing papers by A E Maluish

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A E Maluish. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A E Maluish. The network helps show where A E Maluish may publish in the future.

Co-authorship network of co-authors of A E Maluish

This figure shows the co-authorship network connecting the top 25 collaborators of A E Maluish. A scholar is included among the top collaborators of A E Maluish based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A E Maluish. A E Maluish is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Urba, W J, Ronald G. Steis, Dan L. Longo, et al.. (1990). Immunomodulatory properties and toxicity of interleukin 2 in patients with cancer.. PubMed. 50(1). 185–92. 49 indexed citations

Malozowski, Saúl, et al.. (1988). Lymphocyte subset distribution and natural killer activity in growth hormone deficiency before and during short-term treatment with growth hormone releasing hormone. Clinical Immunology and Immunopathology. 48(1). 85–94. 49 indexed citations

Maluish, A E, Walter J. Urba, Daniele Longo, et al.. (1988). The determination of an immunologically active dose of interferon-gamma in patients with melanoma.. Journal of Clinical Oncology. 6(3). 434–445. 103 indexed citations

Beckner, Suzanne K., A E Maluish, & Dan L. Longo. (1987). Lymphokine-activated killer cells: culture conditions for the generation of maximal in vitro cytotoxicity in cells from normal donors.. PubMed. 47(20). 5504–8. 19 indexed citations

Thurman, Gary B., A E Maluish, Jeffrey L. Rossio, et al.. (1986). Comparative evaluation of multiple lymphoid and recombinant human interleukin-2 preparations.. PubMed. 5(1). 85–107. 13 indexed citations

Yarchoan, Robert, H.-G. Guo, M S Reitz, et al.. (1986). Alterations in cytotoxic and helper T cell function after infection of T cell clones with human T cell leukemia virus, type I.. Journal of Clinical Investigation. 77(5). 1466–1473. 33 indexed citations

Holmes, Pamela A., et al.. (1985). A phase I trial of recombinant gamma interferon in patients with cancer. Cancer Immunology Immunotherapy. 20(3). 193–7. 81 indexed citations

Talmadge, James E., R B Herberman, M. A. Chirigos, et al.. (1985). Hyporesponsiveness to augmentation of murine natural killer cell activity in different anatomical compartments by multiple injections of various immunomodulators including recombinant interferons and interleukin 2.. The Journal of Immunology. 135(4). 2483–2491. 74 indexed citations

Maluish, A E, et al.. (1984). A trial of autologous plasma perfusion over protein A in patients with breast cancer.. PubMed. 3(3). 352–8. 10 indexed citations

10.

Watson, Thelma M., et al.. (1984). A preliminary Phase I trial of partially purified interferon-gamma in patients with cancer.. PubMed. 3(6). 599–607. 19 indexed citations

11.

Goto, Tetsuhisa, R B Herberman, A E Maluish, & D M Strong. (1983). Cyclic AMP as a mediator of prostaglandin E-induced suppression of human natural killer cell activity.. The Journal of Immunology. 130(3). 1350–1355. 147 indexed citations

12.

Maluish, A E, John R. Ortaldo, Stephen A. Sherwin, et al.. (1983). Depression of natural killer cytotoxicity after in vivo administration of recombinant leukocyte interferon.. The Journal of Immunology. 131(1). 503–507. 72 indexed citations

13.

Sherwin, Stephen A., James A. Knost, Seymour Fein, et al.. (1982). A Multiple-Dose Phase I Trial of Recombinant Leukocyte A Interferon in Cancer Patients. JAMA. 248(19). 2461–2466. 112 indexed citations

14.

Gardner, M., A E Maluish, W.J. Halliday, & G. J. A. Clunie. (1975). IMMUNODIAGNOSIS OF A METASTASIS IN A PATIENT WITH A HISTROY OF A DOUBLE MALIGNANT DISEASE. The Medical Journal of Australia. 1(14). 446–448. 1 indexed citations

15.

Halliday, W.J., June W. Halliday, C. B. Campbell, A E Maluish, & Lawrie W. Powell. (1974). Specific Immunodiagnosis of Hepatocellular Carcinoma by Leucocyte Adherence Inhibition. BMJ. 2(5915). 349–352. 18 indexed citations

16.

Halliday, W.J., A E Maluish, & William H. Isbister. (1974). Detection of Anti-tumour Cell Mediated Immunity and Serum Blocking Factors in Cancer Patients by the Leucocyte Adherence Inhibition Test. British Journal of Cancer. 29(1). 31–35. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact